Label: VETONE- lactated ringers sodium chloride,sodium lactate,potassium chloride,calcium chloride injection, solution

  • NDC Code(s): 13985-933-01, 13985-933-05, 13985-933-25, 13985-933-50
  • Packager: MWI
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated September 4, 2018

If you are a consumer or patient please visit this version.

  • STERILE NONPYROGENIC SOLUTIONFor Animal Use Only

    DESCRIPTION

    VetOne Lactated Ringer’s Injection is a sterile, non-pyrogenic solution intended for fluid and electrolyte

    replenishment in single dose containers. May be administered intravenously, subcutaneously or

    intraperitoneally (except in horses) using aseptic technique. It contains no antimicrobial agents.

    Discard any unused portion. Composition, osmolarity, pH and ionic concentration are shown In Table 1

    image description

    *Sodium Lactate USP — (S)-enantiomer

    Osmolarity (mOsmol/L) (calc): 273mOsmol per liter

    pH: 6.5 (limit 6.0 - 7.5)

    The container is free of PVC and phthalates. The container meets the requirements of USP and is

    registered with US FDA.

    CLINICAL PHARMACOLOGY

    A multiple electrolyte intravenous solution is intended to restore the electrolyte balance and water for

    hydration. A combination of multiple electrolytes and sodium lactate, an alkalinizing agent, will

    provide electrolyte balance and normalize the pH of the acid-base of the physiological system.

    INDICATIONS

    VetOne Lactated Ringer′s Injection is indicated as a source of water and electrolytes for all species. It is also

    used as an alkalinizing agent.

    CONTRAINDICATIONS

    VetOne Lactated Ringer′s Injection is contraindicated in patients with a known hypersensitivity to sodium

    lactate; congestive heart failure or severe impairment of renal function; clinical states in which the

    administration of sodium and chloride is detrimental.

    WARNINGS

    The introduction of additives to any solution, regardless of type of container, requires special attention

    to ensure that no incompatibilities result. While some incompatibilities are readily absorbed, one must

    be aware that subtle physical, chemical and pharmacological incompatibilities can occur. The medical

    literature, the package insert and other available sources of information should be reviewed for

    thorough understanding of possible incompatibilities.

    VetOne Lactated Ringer′s Injection should be used with great care, if at all, in patients with congestive heart

    failure, severe renal insufficiency, and in clinical states in which there exists edema and sodium

    retention.

    VetOne Lactated Ringer′s Injection should be used with great care, if at all, in patients with hyperkalemia,

    severe renal failure, and in conditions In which potassium retention is present.

    VetOne Lactated Ringer′s Injection should be used with great care in patients Wth metabolic or

    respiratory alkalosis. The administration of lactate ions should be done with great care in those conditions

    in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.

    VetOne Lactated Ringer′s Injection should not be administered simultaneously with blood through the same

    administration set because of likelihood of coagulation.

    The intravenous administration of VetOne Lactated Ringer′s Injection can cause fluid and/or solute overloading

    resulting in dilution of serum electrolyte concentrations, over-hydration, congested states, or

    pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte

    concentrations of the injections. The risk of solute overloading causing congested states with

    peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the

    injections.

    In patients with diminished renal function, administration of VetOne Lactated Ringer′s Injection may result in

    sodium or potassium retention.

    Do not administer to horses by intraperitoneal injection. Do not administer to animals with inadequate

    renal function. Not for use in lactic acidosis.

    ADVERSE REACTIONS

    Adverse reactions may occur due to the solution or the technique of administration including fever

    response, infection at the site of injection or allergic reactions. Prolonged intravenous infusion of this

    type of product may cause venous thrombosis or phlebitis extending from the site of injection,

    extravasation, and hypervolemia.

    If an adverse reaction does occur discontinue the infusion and evaluate the patient, institute

    appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if

    deemed necessary.

    PRECAUTIONS

    This is a single dose unit. It contains no preservatives. Use entire contents when first opened.

    Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid

    balance, electrolyte concentrations, and acid base balance during prolonged therapy or whenever the

    condition of the patient warrants such evaluation.

    VetOne Lactated Ringer′s Injection should be used with caution. Excess administration may result in metabolic

    alkalosis.

    Do not administer unless solution is clear and both seal and container are intact.

    Solution must be warmed to body temperature prior to administration and administered at a slow rate.

    Use solution promptly following initial entry.

    Reactions which may occur because of the solution or the technique of administration, include febrile

    response, infection at the site of injection, extravasation, and hypervolemia.

    If an adverse reaction occur, discontinue the infusion and evaluate the patient, institute appropriate therapeutic

    countermeasures, and save remainder of the fluid for examination if deemed necessary.

    DOSAGE AND ADMINISTRATION

    To be used as directed by a licensed veterinarian. The dosage of the VetOne Lactated Ringer′s Injection is

    dependent upon the age, weight and clinical conditions of the patient as well as laboratory

    determinations. Parenteral drug products should be inspected visually for particulate matter and

    discoloration prior to administration.

    For use in one patient on one occasion only. Discard any unused portion. Care should be taken with

    administration technique to avoid administration site reactions and infection.

    Additives may be incompatible. Complete information is not available. Those additives known to be

    incompatible should not be used. Consult with Pharmacist, if available. If‚ in the informed judgement of the doctor‚

    it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced.

    Do not store solutions containing additives.

    OVERDOSAGE

    In an event of over-hydration or solute overload, re-evaluate the patient and institute appropriate

    corrective measures. See Warnings, Precautions and Adverse Events.

    PACKS SUPPLIED

    VetOne Lactated Ringer′s Injection in plastic container is available as follows:

    image description

    Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is

    recommended the product be stored at room temperature (86°F/30°C). Protect from freezing.

    DIRECTIONS FOR USE OF PLASTIC CONTAINER

    TO Open

    Tear owerwrap at slit and remove solution container. Some opacity of the plastic due to moisture

    absorption during the sterilization process may be observed. This is normal and does not affect the

    solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing

    solution container firmly. If leaks are found, discard solution as sterility may be impaired. If

    supplemental medication is desired, follow directions below:

    Preparation for Administration

    1. Suspend container from eyelet support.

    2. Remove plastic protector from inlet/outlet port at bottom of container.

    3. Attach administration set.

    TO Add Medication

    WARNING: Additives may be incompatible.

    TO add medication before solution administration

    1. Prepare medication site.

    2. Using syringe with 0.63mm to 0.80mm needle, puncture medication port and inject.

    3. Mix solution and medication thoroughly. For high density medication such as potassium chloride,

    squeeze ports while ports are upright and mix thoroughly.

    TO add medication during solution administration

    1. Close the clamp on the administration set.

    2. Prepare medication site.

    3. Using syringe with 0.63mm to 0.80mm needle, puncture medication port and inject.

    4. Remove container from IV pole and/or turn to an upright position.

    5. Evacuate both ports by squeezing them while container is in the upright position.

    6. Mix solution and medication thoroughly.

    7. Return container to in use position and continue administration.

    CAUTION:

    FEDERAL LAW RESTRICTS THIS DRUG TO USE BY OR ON THE ORDER OF A LICENSED

    VETERINARIAN.

    Made in Australia

    Manufactured by:

    Sypharma Pty Ltd

    27 Healey Road, Dandenong

    Victoria 3175 Australia

    Distributed by: MWI

    Boise,ID 83705

    www.VetOne.net

    Iss.04/18

  • VetoneLactatedRingersInjection250ml

    image description

  • VetoneLactatedRingersInjection500ml

    image description

  • VetoneLactatedRingersInjection1000ml

    image description

  • VetoneLactatedRingersInjection5000ml

    image description

  • INGREDIENTS AND APPEARANCE
    VETONE 
    lactated ringers sodium chloride,sodium lactate,potassium chloride,calcium chloride injection, solution
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:13985-933
    Route of AdministrationINTRAVENOUS, SUBCUTANEOUS, INTRAPERITONEAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE600 mg  in 100 mL
    SODIUM LACTATE (UNII: TU7HW0W0QT) (SODIUM CATION - UNII:LYR4M0NH37, LACTIC ACID - UNII:33X04XA5AT) SODIUM LACTATE310 mg  in 100 mL
    POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152, CHLORIDE ION - UNII:Q32ZN48698) POTASSIUM CHLORIDE30 mg  in 100 mL
    CALCIUM CHLORIDE (UNII: M4I0D6VV5M) (CALCIUM CATION - UNII:2M83C4R6ZB, CHLORIDE ION - UNII:Q32ZN48698) CALCIUM CHLORIDE20 mg  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:13985-933-2524 in 1 CARTON
    1250 mL in 1 BAG
    2NDC:13985-933-5024 in 1 CARTON
    2500 mL in 1 BAG
    3NDC:13985-933-0112 in 1 CARTON
    31000 mL in 1 BAG
    4NDC:13985-933-052 in 1 CARTON
    45000 mL in 1 BAG
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other08/03/2018
    Labeler - MWI (019926120)
    Registrant - Sypharma Pty Ltd (753786292)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sypharma Pty Ltd753786292manufacture, pack, sterilize
    Establishment
    NameAddressID/FEIBusiness Operations
    New Zealand Salt Company Limited594169799api manufacture